I. Chen
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
-
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 5
- Prostate Cancer Treatment and Research 2
- Advanced Breast Cancer Therapies 1
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Robert J. Motzer (5 shared papers)Robert A. Figlin (2 shared papers)Michael Baum (2 shared papers)Dongrui R. Lu (1 shared paper)Santosh Hariharan (1 shared paper)Martin Gore (1 shared paper)Brian I. Rini (1 shared paper)Thomas E. Hutson (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)JNCI Journal of the National Cancer Institute (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
I. Chen
9 papers receiving 602 citations
I. Chen's Hit Papers
Peers
Comparison fields: 5 of 46
- Pulmonary and Respiratory Medicine 360
- Cancer Research 136
- Oncology 158
- Cardiology and Cardiovascular Medicine 79
- Molecular Biology 222
Countries citing papers authored by I. Chen
This map shows the geographic impact of I. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Chen more than expected).
Fields of papers citing papers by I. Chen
This network shows the impact of papers produced by I. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Chen. The network helps show where I. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside I. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Hit paper breakdown → | 2011 | 466 |
| 2 | 2007 | 75 | |
| 3 | 2011 | 34 | |
| 4 | 2007 | 14 | |
| 5 | 2006 | 10 | |
| 6 | 2007 | 6 | |
| 7 | 2007 | 6 | |
| 8 | 2020 | 1 | |
| 9 | 2004 | 1 |
About I. Chen
I. Chen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Oncology and Economics and Econometrics, having authored 9 papers that have together received 613 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Cancer Genomics and Diagnostics (3 papers), Prostate Cancer Treatment and Research (2 papers), Economic and Financial Impacts of Cancer (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Renal and related cancers (2 papers), Advanced Breast Cancer Therapies (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (360 citations), Cancer Research (136 citations), Oncology (158 citations), Cardiology and Cardiovascular Medicine (79 citations) and Molecular Biology (222 citations). I. Chen has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Robert J. Motzer, Robert A. Figlin, Michael Baum, Dongrui R. Lu, Santosh Hariharan, Martin Gore, Brian I. Rini, Thomas E. Hutson, S. T. Kim and Olivier Rixe. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.